EXOSOMM
General Data
Reg Number
516506813
Sector
Biomed
Established
2021
No. of Employees
12
Stage
R&D
Additional Funding
1
Description
Exosomm, founded in December 2021, builds on years of research at Hadassah University Medical Center. Led by Prof. Reif, the team developed EXOSOMM Gut Health™, a powdered formula with milk-derived exosomes that reduce inflammation and support IBD/IB
Technology
Exosomm focused on developing nutritional solutions, based on natural milk exosomes. The company offers a proprietary food formula for medical purposes, specifically targeting inflammatory bowel diseases (IBD) with anti-inflammatory milk exosomes. Exosomm's technology includes an environmentally friendly process for isolating these beneficial exosomes for use in their therapeutic products.
Targeted Customers
Health food stores.
Management personnel
Winning details
Route name
Winning year
The Expedited Program
The Expedited Program
2023
Startup Fund
Startup Fund
2025